Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Microbiology and Immunology
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Open Positions
Programs of Study
Our Faculty
Students & Research Fellows
Publications
News and Events
Toggle News and Events menu options
Events
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Our Faculty
Students & Research Fellows
Publications
News and Events
Home
Publications
You are here
Home
>
Publications
>
Publications
Publications
Found 5 results
Author
Title
Type
[
Year
]
Filters:
Author
is
Melchers, Mark
[Clear All Filters]
2010
Eggink D
,
Melchers M
,
Wuhrer M
,
van Montfort T
,
Dey AK
,
Naaijkens BA
,
David KB
,
Le Douce V
,
Deelder AM
,
Kang K
et al.
. 2010.
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.
.
Virology. 401(2):236-47.
Bontjer I
,
Melchers M
,
Eggink D
,
David K
,
Moore JP
,
Berkhout B
,
Sanders RW
. 2010.
Stabilized HIV-1 envelope glycoprotein trimers lacking the V1V2 domain, obtained by virus evolution.
.
J Biol Chem. 285(47):36456-70.
2011
van Montfort T
,
Melchers M
,
Isik G
,
Menis S
,
Huang P-S
,
Matthews K
,
Michael E
,
Berkhout B
,
Schief WR
,
Moore JP
et al.
. 2011.
A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses.
.
J Biol Chem. 286(25):22250-61.
Melchers M
,
Matthews K
,
de Vries RP
,
Eggink D
,
van Montfort T
,
Bontjer I
,
van de Sandt C
,
David K
,
Berkhout B
,
Moore JP
et al.
. 2011.
A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.
.
Retrovirology. 8:48.
2012
Melchers M
,
Bontjer I
,
Tong T
,
P Y Chung N
,
Klasse PJohan
,
Eggink D
,
Montefiori DC
,
Gentile M
,
Cerutti A
,
Olson WC
et al.
. 2012.
Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.
.
J Virol. 86(5):2488-500.